RFC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.143000E-01
Normal-vs-Stage2
9.661400E-01
Normal-vs-Stage3
6.414000E-01
Normal-vs-Stage4
1.236020E-01
Stage1-vs-Stage2
4.201000E-01
Stage1-vs-Stage3
9.879800E-01
Stage1-vs-Stage4
7.513600E-01
Stage2-vs-Stage3
5.245600E-01
Stage2-vs-Stage4
3.961800E-01
Stage3-vs-Stage4
8.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.325200E-01
Normal-vs-AfricanAmerican
8.159400E-01
Normal-vs-Asian
3.404400E-01
Caucasian-vs-AfricanAmerican
6.495000E-01
Caucasian-vs-Asian
3.259800E-01
AfricanAmerican-vs-Asian
1.993770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.634400E-01
Normal-vs-Female
9.575400E-01
Male-vs-Female
2.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.642040E-02
Normal-vs-Age(41-60Yrs)
7.747200E-01
Normal-vs-Age(61-80Yrs)
6.890800E-01
Normal-vs-Age(81-100Yrs)
7.739400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.56480000004888E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.997440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.452500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.648400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.802400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.950430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.246600E-01
Normal-vs-Daily Drinker
9.120600E-01
Normal-vs-Weekly Drinker
7.924000E-01
Normal-vs-Occasional Drinker
9.489800E-01
Normal-vs-Social Drinker
9.034200E-01
Non Drinker-vs-Daily Drinker
4.830600E-01
Non Drinker-vs-Weekly Drinker
3.670400E-01
Non Drinker-vs-Occasional Drinker
6.956800E-01
Non Drinker-vs-Social Drinker
5.242200E-01
Daily Drinker-vs-Weekly Drinker
7.135000E-01
Daily Drinker-vs-Occasional Drinker
7.410400E-01
Daily Drinker-vs-Social Drinker
9.647600E-01
Weekly Drinker-vs-Occasional Drinker
5.276800E-01
Weekly Drinker-vs-Social Drinker
7.795000E-01
Occasional Drinker-vs-Social Drinker
7.381600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.228800E-01
Normal-vs-Grade 2
7.955800E-01
Normal-vs-Grade 3
8.355200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.354300E-02
Grade 1-vs-Grade 3
1.219640E-02
Grade 1-vs-Grade 4
7.228800E-01
Grade 2-vs-Grade 3
3.030000E-01
Grade 2-vs-Grade 4
7.955800E-01
Grade 3-vs-Grade 4
8.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.722000E-01
Normal-vs-NonDiabetic
9.672000E-01
Diabetic-vs-NonDiabetic
1.998170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.691200E-01
Normal-vs-NoPancreatitis
8.725600E-01
Pancreatitis-vs-NoPancreatitis
1.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.005000E-01
Normal-vs-N1
9.318600E-01
N0-vs-N1
9.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.100200E-01
Normal-vs-TP53-NonMutant
4.794400E-01
TP53-Mutant-vs-TP53-NonMutant
1.82999999999156E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
